Literature DB >> 21378317

Four cardiac hormones cause death of human cancer cells but not of healthy cells.

William P Skelton1, Guillermo E Pi, David L Vesely.   

Abstract

BACKGROUND: Four cardiac hormones, namely, vessel dilator, long-acting natriuretic peptide, atrial natriuretic peptide and kaliuretic peptide, have anticancer effects but whether they cause cell death of human cancer cells or normal cells is unknown.
MATERIALS AND METHODS: These cardiac hormones were examined for their ability to cause cell death quantified by measurement of nuclear matrix proteins 41/7 which is a function of the number of dead or dying cells.
RESULTS: Each of these cardiac hormones caused cell death in up to 36% (p < 0.0001) of the pancreatic adenocarcinoma cells and up to 28% (p<0.0001) of the prostate cancer cells over a concentration range of 100 pmol/l to 10 μmol/l. There was no cell death of normal human prostate, kidney, or lung cells at the above concentrations.
CONCLUSION: Four cardiac hormones cause death of pancreatic and prostate cancer cells but not of normal prostate, lung, or kidney cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21378317

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

Review 1.  The Natriuretic Peptides for Hypertension Treatment.

Authors:  Speranza Rubattu; Giovanna Gallo
Journal:  High Blood Press Cardiovasc Prev       Date:  2021-11-02

2.  Effects of Atrial Natriuretic Peptide on p53 and Estrogen Receptor in Breast Cancer Cells.

Authors:  Katie Aleck; Kelly Hallman; Meghan Quigley; Victoria Lloyd; Monica Szmyd; Dana Ruskin; Tyler Bedgood; Sumi Dinda
Journal:  Biores Open Access       Date:  2017-10-01

3.  Atrial natriuretic peptide: a magic bullet for cancer therapy targeting Wnt signaling and cellular pH regulators.

Authors:  A Serafino; P Pierimarchi
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

4.  Serum atrial natriuretic peptide: a suspected biomarker of breast cancer.

Authors:  Maha E Houssen; Hayam F Ghazy; Kamel Farag; Mona Abo Bakr El-Hussiny; Mohamed A El Ghaffar; Sahar Alsayed Mohamed Alsayed; Omar Farouk
Journal:  Contemp Oncol (Pozn)       Date:  2017-03-22

Review 5.  Natriuretic Peptides: The Case of Prostate Cancer.

Authors:  Letizia Mezzasoma; Matthew J Peirce; Alba Minelli; Ilaria Bellezza
Journal:  Molecules       Date:  2017-10-10       Impact factor: 4.411

6.  A Case of Spontaneous Regression of Pulmonary Small Cell Carcinoma.

Authors:  Motoi Ugajin; Hisanori Kani
Journal:  Eur J Case Rep Intern Med       Date:  2019-07-31

Review 7.  Modified natriuretic peptides and their potential roles in cancer treatment.

Authors:  Mengjiao Xu; Xingzhu Liu; Ping Li; Yadong Yang; Wenyuan Zhang; Siyu Zhao; Ying Zeng; Xile Zhou; Ling-Hui Zeng; Geng Yang
Journal:  Biomed J       Date:  2021-07-06       Impact factor: 7.892

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.